Sanofi (SNYNF) Gains from Sales and Divestitures (2020 - 2021)

Sanofi has reported Gains from Sales and Divestitures for 2 years, with the latest figure at $1.8 billion in Q2 2021.

• Quarterly Gains from Sales and Divestitures changed N/A year-over-year to $1.8 billion in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $1.8 billion (changed N/A YoY) and the FY2020 annual result came in at $1.4 billion, changed N/A from the prior year.
• Gains from Sales and Divestitures improved to $1.8 billion in Q2 2021 per SNYNF's latest filing, from $1.4 billion in the prior quarter.
• Over five years, Gains from Sales and Divestitures peaked at $1.8 billion in Q2 2021 and troughed at $1.4 billion in Q4 2020.